Skip to content

Chol CH3810

by Randox Laboratories, Ltd.

Ref CH3810

Chol CH3810 is a total cholesterol lipid IVD (EU IVDD general IVD; FDA Class I; FDA product code CHH, Enzymatic Esterase--Oxidase, Cholesterol) made by Randox Laboratories, Ltd., registered in EUDAMED on 28 Oct 2026 (Basic UDI-DI B-05055273201284), cleared under FDA 510(k) K923504 on 10 Jan 1994 and listed in FDA GUDID since 24 Dec 2018 (UDI-DI 05055273201284), active as of 7 Nov 2026. 2 FDA recalls are linked to it.

Active European Union and United States. Also listed in GUDID (US).

CE IVDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None ongoing

3 closed

Documents

None, self-declared

Class I: no certifier involved

510(k) K923504

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-05055273201284 Basic UDI-DI 05055273201284UDI-DIDate28 Oct 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number05055273201284 UDI-DI Date24 Dec 2018ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK923504 Date10 Jan 1994DecidedStatusActive

Official records

From the FDA record

Device description
For the quantitative in vitro determination of cholesterol in serum and plasma.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-05055273201284 registered 28 Oct 2026 Active
  • FDA 510(k) K923504 decided 10 Jan 1994 Active
  • FDA GUDID UDI-DI 05055273201284 listed 24 Dec 2018 Listed

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Recalls

3 recalls · FDA

    • Terminated Z-1424-2022 FDA Class II initiated 22 Jun 2022

    Product fails to meet the performance claims quoted on the kit insert: Manual Procedure when calibrating using the standard provided in the kit, the change in absorbance is lower than expected generating internal quality control results high outside range; Cholesterol (CHOL) Instrument Specific Application using the recommended calibration material CAL2351, the product fails to meet its linearity performance claim quoted on the kit inserts. The linearity is reduced by up to -35% however Quality Control results will still fall within assigned ranges. This may lead to delayed results.

    • Terminated Z-0328-2022 FDA Class II initiated 1 Nov 2021

    When calibrating using the standard provided in the kit, the change in absorbance is lower than expected generating internal quality control results high outside range

    • Terminated Z-1652-2016 FDA Class II initiated 17 Mar 2016 on shared 510(k) K923504

    Siemens Healthcare Diagnostics has become aware of N-Acetylcysteine (NAC) and Metamizole (Dipyrone) interference with Trinder and Trinder-like reaction assays. Siemens has confirmed that falsely depressed results may occur on samples drawn from patients receiving N-Acetylcysteine (NAC) or Metamizole. NAC is the accepted antidote for acetaminophen toxicity and is justified in patients at signific

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

6 dated events

  1. Cleared FDA 510(k) K923504
  2. Recall initiated FDA recalls Z-1652-2016
  3. Listed FDA GUDID 05055273201284
  4. Recall initiated FDA recalls Z-0328-2022
  5. Recall initiated FDA recalls Z-1424-2022
  6. Registered EUDAMED B-05055273201284

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Cholesterol (Chol) EUDAMED
Chol GUDID
Generic name
Total cholesterol lipid IVD, kit, spectrophotometry
Model / Ref / Catalog
CH3810
Primary DI / UDI-DI
05055273201284
Basic UDI-DI
B-05055273201284
510(k) Number
FDA product code
CHH
EMDN code
W01010205 Cholesterol
GMDN term
Total cholesterol lipid IVD, kit, spectrophotometry
Device class
Class IVD General EUDAMED
Class I GUDID
Regulation number
862.1175
EU registration type
Legacy device (under a directive)
EU market of registration
Northern Ireland
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class I

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under CHOLESTEROL.

Other devices from Randox Laboratories, Ltd.

See all devices from Randox Laboratories, Ltd. →

Properties

  • Single use
  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (17, all answered No)